相关实验视频

Updated: Jul 1, 2025

Utilizing pHluorin-tagged Receptors to Monitor Subcellular Localization and Trafficking

Utilizing pHluorin-tagged Receptors to Monitor Subcellular Localization and Trafficking

Published on: March 16, 2017

阿尔法5尼古丁乙胆受体子单元促进肝脏内胆瘤转移

Yan Fu^1,2, Keyu Shen^1,3, Hao Wang^1,3

¹Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, 200040, Shanghai, China.

Signal transduction and targeted therapy

|March 7, 2024

概括

肝脏内胆固醇癌 (ICC) 细胞创造了富含乙胆的瘤微环境,通过CHRNA5受体和CAMKII/GSK3β信号传递促进转移. 通过像KN93这样的CAMKII抑制剂准这个轴,可能会提供一种新的ICC治疗策略.

科学领域:

在瘤学瘤学.
神经科学是一个神经科学.
癌症生物学癌症生物学

背景情况:

瘤细胞可以利用神经递质信号进行生长和扩散.
神经递质和神经网络在肝内胆管癌 (ICC) 进展中的作用在很大程度上是未知的.
了解这些相互作用可能会揭示ICC的新治疗点.

研究的目的:

调查ICC是否形成神经网络.
确定神经递质在ICC进展中的作用.
探索针对ICC中神经递质信号的潜在治疗策略.

主要方法:

免疫光染色以可视化ICC细胞和神经透.
与酶相关的免疫吸收试验 (ELISA) 用于量化神经递质水平.
分子路径分析包括受体相互作用,激酶激活和基因表达.

主要成果:

细胞和透的神经创建一个富含乙胆的瘤微环境,通过表皮-介质细胞过渡 (EMT) 促进ICC转移.
乙胆/CHRNA5轴激活GSK3β/β-catenin信号,部分通过Ca2+流入和CAMKII激活.
乙胆信号通过增加来自大脑的神经营养因子 (BDNF) 来增强神经透,形成一个积极的反循环.
该CAMKII抑制剂KN93降低了ICC细胞迁移,并增加了对gemcitabine的敏感性.

结论:

乙胆/CHRNA5轴通过CAMKII/GSK3β信号传导驱动ICC转移和耐吉他耐药性.
用KN93等抑制剂向CAMKII通路,为ICC治疗提供了一个有前途的治疗途径.
这项研究强调了瘤神经微环境在ICC进展中的重要性.

更多相关视频

Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons

Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons

Published on: June 24, 2015

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

相关概念视频

Cholinergic Receptors: Nicotinic

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...

Cholinergic Receptors: Muscarinic

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....

Cholinergic Neurons: Neurotransmission

Cholinergic Neurons: Neurotransmission

Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...

Activation of Integrins

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...